Kallikrein-kinin in stroke, cardiovascular and renal disease (Q36011348)

11 August 2017

1 reference

title

Kallikrein-kinin in stroke, cardiovascular and renal disease (English)

1 reference

11 August 2017

Julie Chao

1

1 reference

PubMed ID

15653716

11 August 2017

Lee Chao

series ordinal

2

1 reference

11 August 2017

14 January 2005

1 reference

11 August 2017

Experimental Physiology

1 reference

11 August 2017

90

1 reference

11 August 2017

3

1 reference

11 August 2017

291-298

1 reference

Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction

11 August 2017

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Hypertension in Dahl salt-sensitive rats: biochemical and immunohistochemical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Kallistatin is a potent new vasodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Identification of a new tissue-kallikrein-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Kinin receptors in pain and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Dilated and failing cardiomyopathy in bradykinin B(2) receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Kinin B1 receptors: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Kallistatin is a new inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Adenovirus-mediated kallikrein gene transfer inhibits neointima formation via increased production of nitric oxide in rat artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Urinary enzymes, nephrotoxicity and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

DNA polymorphisms in the 5'-flanking region of the human tissue kallikrein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Central delivery of human tissue kallikrein gene reduces blood pressure in hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Hypotension in transgenic mice overexpressing human bradykinin B2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Gene therapy with human tissue kallikrein reduces hypertension and hyperinsulinemia in fructose-induced hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.028464

10.1113/EXPPHYSIOL.2004.028464

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15653716